Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BiolineRx
company
About
BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2003
- Number Of Employee
- 51 - 100
- Operating Status
- Active
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
BiolineRx has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2022 | Post-IPO Debt | $10M | 1 |
Kreos Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
BiolineRx is funded by 1 investors.
Kreos Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kreos Capital
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
